Article

iVue Normative Database gets 510(k) clearance

Optovue has received FDA 510(k) clearance for the Normative Database for the iVue spectral-domain optical coherence tomography (SD-OCT) system.

 

Fremont, CA-Optovue has received FDA 510(k) clearance for the Normative Database for the iVue spectral-domain optical coherence tomography (SD-OCT) system. The Normative Database provides analysis information to be used as a clinical reference to aid in the diagnosis and management of ocular health and disease.

The iVue Normative Database provides quantitative comparisons of the retina, retinal nerve fiber layer, ganglion cell complex, and optic disc measurements to aid in the evaluation of various ocular pathologies. After scans are captured, the normative comparison analysis adjusts for the patient’s age, optic disc size, and scan signal strength. Symmetry and change analyses combined with normative comparisons support patient evaluation and management.

The Normative Database is included with any iVue SD-OCT system purchase and a new software update will be provided free of charge to all current iVue owners of record. This update is expected to be available in early March.

 

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.